Our unique technology enables any user of a healthcare organization to organize, access, and protect the privacy of patient data, empowering healthcare workers to rapidly transform ideas into actionable insights and take action.
MDClone was awarded Best Healthcare Big Data Platform by the MedTech Breakthrough Awards in 2021, 2022, and 2023. MDClone was also selected as a Technology Pioneer by the World Economic Forum in 2021 for the powerful MDClone ADAMS Platform.
Current customers include Washington University School of Medicine in St. Louis, Intermountain Healthcare, the Regenstrief Institute, the VHA Innovation Ecosystem, The National Institutes of Health, The Ottawa Hospital, and Jewish-General Hospital in North America. In Israel, MDClone serves 100% of the Israeli healthcare market. MDClone is backed by some of the most prominent investors in the U.S. and Israel: aMoon, Lightspeed, OrbiMed, Warburg Pincus, and Viola Growth.
Discover why more health systems are using the MDClone ADAMS platform to unlock the discoveries of the future:
Beckers: UChicago Medicine creating innovation hub
HealthcareIT News: Jewish General uses self-service platform, synthetic data to democratize analytics
Chief Healthcare Executive: How Jewish General Hospital is gaining more insights from data
HealthIT Answers: Improving Patient Outcomes with an Innovative Approach to Data
The MDClone ADAMS Platform enables users to engage in independent self-service data investigation. Unlike traditional data analysis tools built for predictable, operational reporting, ADAMS focuses on data investigation and exploration so users can find the “why” answers behind clinical scenarios. Users can interact with patient data from any source, leverage unstructured data, and use Adam, a GPT Generative AI research assistant, to help them pull insights from their investigation.
The ADAMS platform has two key benefits over other, traditional analytics tools:
The ADAMS Center operational model aims to align the health system leadership and the front-line workforce towards the goal of increased volume of insight generation and the value those insights can deliver for hospital operations and ultimately patient health. The promise of building a learning health system doesn’t come from operational reporting tools but instead from enabling an organization full of talent to explore and discover opportunities within their data.
Sharing Health Data is Laborious and Burdened by Barriers. The ADAMS Platform overcomes these common obstacles by allowing users to safely and securely share data and information across both internal and external entities with synthetic data.
With synthetic data, you are able to:
Explore data independent of IRB process
Maintain patient privacy
Share data worldwide
What is Synthetic Data? Non-reversible, artificially created data that replicates the statistical characteristics and correlations of real-world, raw data. Learn more with the following resources:
